222716-86-1
222716-86-1
Chemical Structure
Pegaptanib sodium
Synonym(s): EYE001; NX1838
- CAS No.: 222716-86-1
- Formula:N/A
- Molecular Weight:50000 (Approximately)
SMILES: [Pegaptanib (sodium)]
Biological Activity: Pegaptanib sodium is an RNA aptamer with polyethylene glycol modifications, which is directed against vascular endothelial growth factor (VEGF)-165. Pegaptanib could be used for the study of neovascular age-related macular degeneration (AMD) [1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Pegaptanib sodium | 90.51% | Pegaptanib sodium is an RNA aptamer with polyethylene glycol modifications, which is directed against vascular endothelial growth factor (VEGF)-165. Pegaptanib could be used for the study of neovascular age-related macular degeneration (AMD) . | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pegaptanib sodium (Standard) | ≥98% | Pegaptanib sodium (Standard) is the analytical standard of Pegaptanib (sodium) (HY-109561). This product is intended for research and analytical applications. Pegaptanib sodium is an RNA aptamer with polyethylene glycol modifications, which is directed against vascular endothelial growth factor (VEGF)-165. Pegaptanib could be used for the study of neovascular age-related macular degeneration (AMD) . | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
